Whitney Melton
About Whitney Melton
Whitney Melton is an Immuno Oncology Product Specialist with over 8 years of experience in the oncology field, currently working at Bristol-Myers Squibb in Indianapolis, Indiana.
Title
Whitney Melton currently holds the position of Immuno-Oncology Product Specialist. She has been actively involved in the oncology field for over 8 years, contributing her expertise to improve patient care and product knowledge.
Current Role at Bristol-Myers Squibb
Since March 2015, Whitney Melton has been working as an Immuno-Oncology Product Specialist at Bristol-Myers Squibb, based in Indianapolis, Indiana, United States. In this role, she leverages her extensive background in oncology to support the development and implementation of cancer treatment products. Her deep understanding of immuno-oncology allows her to provide valuable insights and enhance the effectiveness of therapeutic solutions.
Previous Experience at Insys Therapeutics
Before joining Bristol-Myers Squibb, Whitney Melton worked at Insys Therapeutics, Inc. as an Oncology Nurse Educator. She held this position for 8 months from 2014 to 2015, also in Indianapolis, Indiana. During her tenure, she was responsible for educating healthcare professionals about oncology treatments, drawing on her clinical experience to provide comprehensive and accurate information.
Educational Background
Whitney Melton completed her Bachelor of Science in Nursing at Indiana University–Purdue University Indianapolis. Her academic background laid a strong foundation for her specialization in oncology, equipping her with the necessary skills and knowledge to excel in both clinical and educational roles within the healthcare sector.
Clinical and Educational Roles at Indiana University Health
From 2012 to 2014, Whitney Melton served as an RN, BSN, OCN at Indiana University Health. Her responsibilities included direct patient care, addressing complex oncology cases, and providing specialized nursing care. Her dual experience in clinical practice and education has enabled her to bridge the gap between patient care and therapeutic product development effectively.